Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

HEALTHCARE (NY: XLV )

146.95 +0.78 (+0.53%)
Official Closing Price Updated: 8:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
22 23 Next >
April Is Busting Out For Healthcare And Biotech
Last week was a good week for healthcare stocks and most large cap biopharmaceutical stocks resumed an upward trend. 
Via Talk Markets
Weekly Market Pulse: History Lessons
Studying the past doesn’t somehow allow us to predict the future. But it does tell us that there is a range of potential outcomes and we should be reluctant to make big changes to our portfolios based... 
Via Talk Markets
GILD - Chart Of The Week
The daily chart looks pretty strong right now. The stock is trying to break through the resistance line that started around the beginning of December. 
Via Talk Markets
Recession Playbook In Action: Cooling Labor Market Triggers Rally In Treasuries, Gold; Stocks Decline
Recent economic data has prompted investors to hedge against the rising likelihood of a recession.  In February 2023, there were 9.9 million job openings, which was the lowest level since May 2021 and... 
Via Benzinga
Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags
It was very difficult to make money in Q1 trading healthcare or biotech ETFs because of the sharp rally in other sectors. Nonetheless, there were two big winners. 
Via Talk Markets
Financials And Tech Continue To Split: Your Sector Trade Ideas For The Week Ahead
Current trade opportunities for Financials and Tech along with other sectors setting up trade logic. 
Via Talk Markets
Energy & Financials Lead, But The Flight To Quality Has Begun
It's easy to get suckered into thinking the crisis is over and buy the most oversold stocks. For financials, this comes with significant risk as the 
Via Talk Markets
Can Healthcare Stocks Survive Macro Headwinds?
Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year. 
Via Talk Markets
Sector Performance Experiences A Historical Divergence
The first quarter of 2023 is coming to a close next week, and checking in on year-to-date performance, there has been a big divergence between the winners and losers. 
Via Talk Markets
Small Cap Biotechs Slammed By SVB Collapse
Nothing like a banking crisis to start off a weekend. But maybe by the end of this upcoming week of turmoil we'll worry less about inflation. 
Via Talk Markets
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
Via Benzinga
U.S. Weekly Fund-Flows Insight Report: Investors Embrace Both Fixed Income And Equity ETFs
As investors appeared to ignore rising Treasury yields, stocks generally managed to remain on the plus-side for the fund-flows week. 
Via Talk Markets
Covis Pharma To Withdraw Only FDA-Approved Treatment To Prevent Preterm Births
Via Benzinga
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
Via Benzinga
A Market And Economy Exceeding Expectations
Knowing the economy and investment market are not one and the same, and can function out of sync at times, possibly the current environment is such that they are actually in sync. 
Via Talk Markets
S&P 500 2022 Q4 Earnings Review: Swing And A Miss
In many ways, this quarter behaved in a way that met the expectations of most market commentators, earnings are too high, an erosion of pricing power since the pandemic, and that higher costs will bite... 
Via Talk Markets
Identifying The Dimension Where Deterministic Chaos Is Alive In The Stock Market
We have estimated approximate entropy for the S&P 500 and its SPDR ETF and we have noticed that all of them have non-linear dependence patterns for the dimension of 3 or 4 days. 
Via Talk Markets
Tuesday Talk: My Sweet CPI
The street is hoping for sweet January CPI data today and that anticipation pushed stocks higher on Monday. 
Via Talk Markets
Large-Cap Biopharmaceuticals: Bearish Sentiment Curbs Buyers
Large cap biopharma stocks are off their highs despite reasonable valuations plus dividends. 
Via Talk Markets
A Bull Market Is Coming. Should You Return to Growth Stocks?
Growth stocks could be among the first to rally in a bull market. 
Via The Motley Fool
This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 Years
Funneling money into this fund can drastically simplify your investing strategy. 
Via The Motley Fool
10 Names For Half The Move
In January, sectors like Tech, Communication Services, and Consumer Discretionary saw massive outperformance following the opposite playing out throughout 2022. 
Via Talk Markets
Sector Divergence, Earnings Stats
Over these last few weeks, as the broad market has rallied, we've definitely seen some sector divergence. 
Via Talk Markets
Sector Shift Stalls Healthcare Stocks But Biotech Shows Gains In January
Biotech stocks are off to a great start in 2023 with the IBB up 4.5% and the XBI up 7.7%. 
Via Talk Markets
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength. 
Via Talk Markets
Rotating Regimes – What To Plan For In 2023
Throughout the second half of 2022, active managers turned to sector rotation to help mitigate and recover from substantial losses incurred already. Rotation into and out of low and high volatility... 
Via Talk Markets
Markets At Key Turning Point With Major Earnings Ahead
We saw initial selling in the market today and will be watching this particular key price level very closely this week and beyond. 
Via Talk Markets
Top Sector For 2023
Technical analysis and opinion on each sector in the stock market and which ones are likely to do the best, and which ones are most likely to lag the overall market. 
Via Talk Markets
Best ETFs, Funds, and Stocks of 2022. A Preview to 2023.
In 2022, high inflation and rising bond yields emerged as headwinds for stocks. The S&P 500 declined by over 18%, marking its worst yearly showing since 2008. 
Via Talk Markets
Nice Gains During JPM23 Week: Benign CPI Report Brings Hope For A “Soft Landing”
Small-cap speculative biotech stocks regain interest with volatility. 
Via Talk Markets
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
22 23 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.